Evidence map›Paper›PMID 27594791›Full record

ArticleClinical Medicine Insights. Cardiology2014

Inflammation, Atherosclerosis and Coronary Artery Disease.

Yukihiko Momiyama, Hisashi Adachi, DeLisa Fairweather, Nobukazu Ishizaka, Emi Saita

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical Medicine Insights. Cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Observational
  6. Chemerin/ChemerinR1 axis and inflammation-related diseases.Frontiers in molecular biosciences · 2026
    Review
  7. Article
  8. Article
  9. [Three-dimensional printed 316L stainless steel cardiovascular stent's electrolytic polishing and its mechanical properties].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yukihiko MomiyamaDirector, Department of Cardiology, NHO Tokyo Medical Center, Tokyo, Japan.
Hisashi AdachiProfessor, Department of Community Medicine, Kurume University School of Medicine, Kurume, Japan.
DeLisa FairweatherAssociate Professor of Cardiovascular Diseases, Mayo Clinic, Jacksonville, FL, USA.
Nobukazu IshizakaProfessor, Faculty of Medicine, Department of Cardiology, Osaka Medical College, Osaka, Japan.
Emi SaitaLecturer, Endowed Research Department "Food for Health", Ochanomizu University, Tokyo, Japan.

Funding

Sex Differences in Complement during Myocarditis/DCMR01HL111938 · NHLBI · MAYO CLINIC JACKSONVILLE · PI FAIRWEATHER, DELISA · 2012 to 2015
$1.6M
Endocrine disruptors effect on inflammatory heart diseaseR21ES024414 · NIEHS · MAYO CLINIC JACKSONVILLE · PI FAIRWEATHER, DELISA · 2014 to 2015
$440k
NHLBI NIH HHS R01 HL111938NIEHS NIH HHS R21 ES024414
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27594791
PMCPMC5003124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.